SCHEMBL9113385

SCHEMBL9113385

COc1cc2ncnc(N3c4ccccc4CC3CO)c2cc1OC

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.57
CSF1R P07333 1/20 0.56
HTR7 P34969 3/20 0.50
PDE10A Q9Y233 3/20 0.50
HTR1A P08908 2/20 0.50
ACHE P22303 6/20 0.49
BACE1 P56817 6/20 0.49
RET P07949 2/20 0.48
KIF5B P33176 1/20 0.48
KDR P35968 1/20 0.48
KIT P10721 2/20 0.48
AURKA O14965 2/20 0.46
PDE3A Q14432 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8647403 0.84 EGFR (0.61) EGFRCSF1RHTR7PDE10AHTR1A
SCHEMBL27477800 0.84 EGFR (0.60) EGFRCSF1RHTR7PDE10AHTR1A
SCHEMBL8647902 0.81 EGFR (0.55) EGFRCSF1RHTR7PDE10AHTR1A
Lithium Ion SCHEMBL8650898 0.81 EGFR (0.55) EGFRCSF1RHTR7PDE10AHTR1A
SCHEMBL8650896 0.81 EGFR (0.55) EGFRCSF1RHTR7PDE10AHTR1A
Lithium SCHEMBL8650904 0.81 EGFR (0.55) EGFRCSF1RHTR7PDE10AHTR1A
SCHEMBL4718427 0.78 EGFR (0.65) EGFRCSF1RHTR7PDE10AHTR1A
Hydrochloric Acid SCHEMBL6181670 0.77 EGFR (0.66) EGFRCSF1RHTR7PDE10AHTR1A
SCHEMBL4399739 0.74 HTR7 (0.53) EGFRCSF1RHTR7PDE10AHTR1A
SCHEMBL5468434 0.73 ACHE (0.68) EGFRCSF1RHTR7PDE10AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1141633-A 4-heterocyclic substituted quinazoline derivatives, process for their preparation and their use as anticancer agents PFIZER (US) 1997-01-29 CN disclosed
WO-1995023141-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1995-08-31 WO disclosed